Flatiron’s key insight was that, in cancer, half or more of the most important data in health records isn’t in structured data fields, but rather in unstructured data, the free text fields of pathology reports and clinical notes, and extracting this information (at least today) requires people.
Original Article: The Deeply Human Core of Roche's $2.1B Tech Acquisition - And Why They Did It